The signaling of FGF receptor-19 (FGFR19) and FGFR4 enabled the survival of breast cancer cells lines co-expressing them via the activation of PI3K/Akt pathway, targeting FGFR4/FGF19-sensitized cancer cells to death (52). Here, AKT1 is linked to breast carcinoma.